A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.

@article{Mulholland2003ADP,
  title={A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.},
  author={Ciaran Mulholland and Gerard Lynch and David J. King and Stephen J. Cooper},
  journal={Journal of psychopharmacology},
  year={2003},
  volume={17 1},
  pages={
          107-12
        }
}
There have been no studies specifically examining the efficacy of selective serotonin reuptake inhibitor antidepressants for the symptoms of depression in schizophrenia. This study aimed to determine the efficacy and safety of sertraline as a treatment for depressive symptoms in patients with stable, chronic schizophrenia. The Beck Depression Inventory (BDI) was used as the principal outcome measure and other measures of depressive symptoms as secondary outcome measures. Twenty-six patients… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations